Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 22 min ago
PreprintAll rights reservedbioRxiv

Discovery of GluA3 preferring AMPA receptor positive allosteric modulator BRD3290

  • C. Greaves
  • W. E. Martenis
  • S. D. Nelson
  • J. Madison
  • A. Skepner
  • D. Baez-Nieto
  • K. J. Stalnaker
  • E. P. Lebois
  • A. J. Campbell
  • K. Pelham
  • M. Magdei
  • A. Guletsky
7 more authors
  • K. Perez de Arce
  • Y.-L. Zhang
  • F. F. Wagner
  • J. Q. Pan
  • M. Weïwer
  • M. Sheng
  • S. P. Moran1
  1. 1Broad Institute of MIT and Harvard
Read full textPDFDOICite

Related

  1. The α2‐Subunit Preferring GABA Positive Allosteric Modulator, N‐Desmethyl‐Clobazam in Peripheral Neuropathic Pain Patients: Results of a Phase IIa Randomised Placebo‐Controlled Ascending Dose Study
    M. Besson, A. Matthey, Y. Daali +4
    European journal of pain (London, England)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Peptide-Linked Bivalent Nanobody Constructs as Positive Allosteric Modulators of the Calcium-Sensing Receptor.
    Mahdis Nabipour, Charlotte Hagen Skadhauge, Line Juel Rasmussen +3
    Basic & clinical pharmacology & toxicologyPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCPMC
  3. AT1R-Selective Negative Allosteric Modulator Targeting the Epitope for Pathogenic Autoantibody Activation
    K. D. Singh, T. R. Pardhi, T. J. Harford +6
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxiv
  4. A Phase 1 Study of MK-1942, a Negative Allosteric Modulator of mGluR2, in Healthy Japanese to Flexibly Assess Factors Including CYP2C19 Phenotype.
    Chihiro Hasegawa, Yohei Doi, Tomona Hirano +10
    Clinical and translational sciencePeer-reviewedCC BY-NCFull textPharmacology & toxicologyEurope PMC
  5. Positive Allosteric Modulation of mGlu and Muscarinic Receptors Differentially Regulate Nitric Oxide-Dependent Signaling in a Scopolamine-Induced Model of Cognitive Impairment
    Grzegorz Burnat, Michał Santocki, Anna Siekierzycka +3
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{greaves2026discovery,
  title = {{Discovery of GluA3 preferring AMPA receptor positive allosteric modulator BRD3290}},
  author = {C. Greaves and W. E. Martenis and S. D. Nelson and J. Madison and A. Skepner and D. Baez-Nieto and K. J. Stalnaker and E. P. Lebois and A. J. Campbell and K. Pelham and M. Magdei and A. Guletsky and K. Perez de Arce and Y.-L. Zhang and F. F. Wagner and J. Q. Pan and M. Weïwer and M. Sheng and S. P. Moran},
  howpublished = {bioRxiv},
  year = {2026},
  month = jul,
  doi = {10.64898/2026.07.26.740780},
  url = {https://www.biorxiv.org/content/10.64898/2026.07.26.740780v2},
}
RIS
TY  - UNPB
TI  - Discovery of GluA3 preferring AMPA receptor positive allosteric modulator BRD3290
AU  - C. Greaves
AU  - W. E. Martenis
AU  - S. D. Nelson
AU  - J. Madison
AU  - A. Skepner
AU  - D. Baez-Nieto
AU  - K. J. Stalnaker
AU  - E. P. Lebois
AU  - A. J. Campbell
AU  - K. Pelham
AU  - M. Magdei
AU  - A. Guletsky
AU  - K. Perez de Arce
AU  - Y.-L. Zhang
AU  - F. F. Wagner
AU  - J. Q. Pan
AU  - M. Weïwer
AU  - M. Sheng
AU  - S. P. Moran
PY  - 2026
DA  - 2026/07/26
PB  - bioRxiv
DO  - 10.64898/2026.07.26.740780
UR  - https://www.biorxiv.org/content/10.64898/2026.07.26.740780v2
ER  -